首页|辅酶A辅助无创正压通气治疗慢性阻塞性肺疾病急性加重的效果观察

辅酶A辅助无创正压通气治疗慢性阻塞性肺疾病急性加重的效果观察

扫码查看
目的 分析辅酶A辅助无创正压通气治疗慢性阻塞性肺疾病(慢阻肺)急性加重的效果。方法 选取某院 2021~2023 年的 92例慢阻肺急性加重患者,随机分成两组。对照组(46 例)采用无创正压通气进行治疗,研究组(46 例)采用辅酶A辅助无创正压通气进行治疗。比较两组患者血气指标、血清指标、免疫功能。结果 治疗前后,两组PaO2、PaCO2 差异无统计学意义(P>0。05);治疗后,研究组pH高于对照组(P<0。05);治疗后,研究组铁、锌水平低于对照组,CD4+、CD4+/CD8+水平高于对照组,CD8+低于对照组(P<0。05)。结论 辅酶A辅助无创正压通气治疗慢阻肺急性加重效果更好,可改善患者免疫功能,纠正患者铁、锌含量。
Observation on the effect of non-invasive positive pressure ventilation assisted by coenzyme A in the treatment of acute exacerbation of chronic obstructive pulmonary diseases
Objective To analyze the effect of non-invasive positive pressure ventilation assisted by coenzyme A on acute exacerbation of chronic obstructive pulmonary disease(COPD).Methods 92 patients with acute COPD exacerbation from 2021 to 2023 were randomly divided into two groups.The control group(n=46)was treated with non-invasive positive pressure ventilation,and the study group(n=46)was treated with non-invasive positive pressure ventilation assisted by coenzyme A.Blood gas index,serum index and immune function were compared between the two groups.Results There was no significant difference in PaO2 and PaCO2 between the two groups before and after treatment(P>0.05).After treatment,the pH of the study group was higher than that of the control group(P<0.05).After treatment,iron and zinc levels in the study group were lower than those in the control group,CD4+,CD4+/CD8+levels were higher than those in the control group,and CD8+levels were lower than those in the control group(P<0.05).Conclusion Coenzyme A assisted non-invasive positive pressure ventilation is more effective in the treatment of acute COPD exacerbation,which can improve the immune function and correct the content of iron and zinc in patients.

Coenzyme ANon-invasive positive pressure ventilationAcute exacerbation of COPDEffect observation

王萌萌、王辰、欧阳文浩、胡斌

展开 >

上海市徐汇区中心医院呼吸与危重症医学科,上海 200031

辅酶A 无创正压通气 慢性阻塞性肺疾病急性加重 效果观察

2024

中国处方药
南方医药经济研究所

中国处方药

影响因子:0.649
ISSN:1671-945X
年,卷(期):2024.22(7)